Man Group plc bought a new position in National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 9,276 shares of the company's stock, valued at approximately $1,961,000. Man Group plc owned 0.06% of National HealthCare at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Strs Ohio purchased a new position in National HealthCare during the 4th quarter valued at about $809,000. Militia Capital Management LLC bought a new position in shares of National HealthCare during the first quarter valued at approximately $2,827,000. Morgan Stanley Institutional Investment Advisors LLC boosted its stake in shares of National HealthCare by 38.6% during the fourth quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company's stock valued at $142,407,000 after purchasing an additional 289,566 shares in the last quarter. BlackRock Inc. purchased a new position in National HealthCare during the second quarter valued at approximately $417,602,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in National HealthCare by 407.2% in the first quarter. Arrowstreet Capital Limited Partnership now owns 75,257 shares of the company's stock worth $12,019,000 after buying an additional 60,420 shares in the last quarter. Hedge funds and other institutional investors own 56.44% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have recently issued reports on NHC shares. Royal Bank Of Canada upgraded National HealthCare to a "hold" rating in a report on Monday, May 18th. Robert W. Baird upgraded shares of National HealthCare to a "strong-buy" rating in a report on Monday, May 18th. The Goldman Sachs Group upgraded shares of National HealthCare to a "strong-buy" rating in a report on Monday, May 18th. Finally, BMO Capital Markets upgraded shares of National HealthCare to a "hold" rating in a research note on Monday, May 18th. Two investment analysts have rated the stock with a Strong Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Buy".
View Our Latest Analysis on NHC
National HealthCare Price Performance
Shares of NHC opened at $218.97 on Wednesday. The company's fifty day moving average price is $220.05 and its 200-day moving average price is $190.81. National HealthCare Corporation has a 1-year low of $111.24 and a 1-year high of $239.29. The firm has a market capitalization of $3.43 billion, a PE ratio of 24.63 and a beta of 0.62.
National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.74 EPS for the quarter. The company had revenue of $408.03 million during the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.
National HealthCare Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.67 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.2%. National HealthCare's payout ratio is 61.89%.
Insider Buying and Selling
In related news, Director David R. Gifford sold 1,779 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $225.42, for a total value of $401,022.18. Following the transaction, the director owned 1,030 shares in the company, valued at approximately $232,182.60. This represents a 63.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen Fowler Flatt sold 1,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $237.08, for a total transaction of $355,620.00. Following the transaction, the chief executive officer directly owned 65,487 shares of the company's stock, valued at $15,525,657.96. This represents a 2.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 13.92% of the stock is owned by corporate insiders.
About National HealthCare
(
Free Report)
National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.
Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider National HealthCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.
While National HealthCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.